U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07038096) titled 'ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma' on June 18.
Brief Summary: This study is a randomized, multicenter, Phase Ib/II clinical trial, aimed at evaluating the efficacy and safety of the combination of ZG006 and ZG005 in patients with advanced small cell lung cancer and neuroendocrine carcinoma.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Small Cell Lung Cancer
Neuroendocrine Carcinoma
Intervention:
DRUG: ZG006
ZG006 will be administered as an intravenous (IV) infusion.
DRUG: ZG005
ZG005 will be administered as an intravenous (IV) infusion.
Recruitment...